Published December 21, 2020 | Version v1
Journal article Open

Carbapenem Resistance in Klebsiella pneumoniae and Escherichia Coli at Dr. Muhammad Hoesin Central General Hospital, Palembang

Description

OXA-48 is a class D β-lactamase which is not inhibited by clavulanic acid, tazobactam and sulbactam, because their activity may be inhibited in vitro by NaCl. Some b-lactamase enzymes hydrolyze carbapenem and are therefore defined as hydrolysis of class D carbapenem b-lactamase. Carbapenem-resistant Klebsiella pneumoniae isolates were found in Istanbul, Turkey, in 2001. OXA-48 produces isolates that have the ability to fight drugs and cause very beneficial resistance to β-lactams, including widely available cephalosporins, cephamycins, and monobactone and carbapenem. The OXA-48 gene is found on plasmids. Antibiotic resistance is a phenomenon taken from the discovery of antibiotics where there is a very good adaptability for bacteria which are treated with various antibiotics. It has bacteria that have the ability to mutate as a protection for survival. This study is a case study involving the OXA gene as an encoder for carbapenem in Escherichia coli and Klebsiella pneumoniae using the Polymerase Chain Reaction (PCR) method to use genotypes used in hospitals that can be used in Dr. RSUP. Mohammad Hoesin Palembang. Bacterial isolates derived from patients with Klebsiella pneumoniae and Escherichia coli infections in the period September-November 2017 were identified using Vitek 2 Compact. blaOXA-48 gene was detected by PCR, followed by visualization through electrophoresis. The detection results were then analyzed by comparing the pattern of antibiotic resistance. From 24 samples tested only 1 (4.7%) positive samples were obtained from the bacterium Klebsiellapneumoniae and no positive gene was found in Escherichia coli. This study identified 1 (4.2%) samples that had a positive OXA-48 gene while 23 (95.8%) samples had a negative OXA-48 gene.

Files

fitrizalFIN.pdf

Files (339.9 kB)

Name Size Download all
md5:0be57a1f647471da8078524d9e126b54
339.9 kB Preview Download

Additional details

References

  • Jawetz, Melnick, Adelberg. Mikrobiologi Kedokteran, Edisi I. Diterjemahkan oleh Bagian Mikrobiologi Fakultas Kedokteran Universitas Airlangga. 2001.
  • Tenaillon O, Skurnik D, Picard B, Denamur E. The population genetics of commensal Escherichia coli. Nature Reviews Microbiology. 2010.
  • Rhomberg PR, Jones RN. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008). Diagn Microbiol Infect Dis. 2009. 65(4).414–26. https://linkinghub.elsevier.com/retrieve/pii/S0732889309003629
  • Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother. 2012. 67(7):1597–606. https://academic.oup.com/jac/article-lookup/doi/10.1093/jac/dks121
  • Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004. 48(1). 15–22. https://aac.asm.org/content/48/1/15
  • Meletis G. Carbapenem resistance: overview of the problem and future perspectives. Ther Adv Infect Dis. 2016. 3(1). 15–21. http://journals.sagepub.com/doi/10.1177/2049936115621709
  • Spanu T, Sanguinetti M, Ciccaglione D, D'Inzeo T, Romano L, Leone F, et al. Use of the VITEK 2 System for Rapid Identification of Clinical Isolates of Staphylococci from Bloodstream Infections. J Clin Microbiol. 2003.41(9).4259–63. http://jcm.asm.org/cgi/doi/10.1128/JCM.41.9.4259-4263.2003
  • Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011.70(1). 119–23. https://linkinghub.elsevier.com/retrieve/pii/S0732889310005559
  • Potron A, Poirel L, Rondinaud E, Nordmann P. Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Eurosurveillance. 2013. 18(31). 20549.
  • Lyman M, Walters M, Lonsway D, Rasheed K, Limbago B, Kallen A. Notes from the Field : Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases — United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2015. 64(47):1315–6. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6447a3.htm
  • Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Eurosurveillance. 2015.20(45).30062. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=21300
  • Malbruny B, Le Marrec G, Courageux K, Leclercq R, Cattoir V. Rapid and efficient detection of Mycobacterium tuberculosis in respiratory and non-respiratory samples [Technical note]. Int J Tuberc Lung Dis. 2011.15(4).553–5. http://www.ingentaconnect.com/content/10.5588/ijtld.10.0497
  • Rousseau C, Poilane I, De Pontual L, Maherault A-C, Le Monnier A, Collignon A. Clostridium difficile Carriage in Healthy Infants in the Community: A Potential Reservoir for Pathogenic Strains. Clin Infect Dis. 2012.55(9).1209–15. https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/cis637
  • Morrill HJ, Pogue JM, Kaye KS, LaPlante KL. Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections. Open Forum Infect Dis. 2015.2(2). https://academic.oup.com/ofid/article/doi/10.1093/ofid/ofv050/1412414